Why the study?
Elucidating how phosphorylation at serines 22 and 23 modulates cardiac troponin structural dynamics has been difficult because key regulatory segments are unresolved.
Molecular dynamics simulations reveal that phosphorylation rigidifies wild-type cardiac troponin, whereas it reverses structural metrics in the dilated cardiomyopathy-associated G159D mutation.
Hypothesis-generating for troponin regulation in stress; leaves open translation to clinical adrenergic modulation.
Phosphorylation of cardiac muscle troponin I by protein kinase A enhances troponin regulatory dynamics and is an essential part of the’ flight or fight’ response to adrenaline. Elucidating how phosphorylation at serines 22 and 23 modulates structural dynamics has been difficult as key regulatory segments of troponin are unresolved. The effect of phosphorylation on the wild type, obtained from all-atom molecular dynamics simulations of the troponin core, demonstrates a significant rigidification of the structure that involves a rearrangement of the cTnI(1-33) - cTnC interaction, and changes in the distribution of the cTnC helix A/B angle and the interdomain angle, between the regulatory head and ITC arm. The familiar dilated cardiomyopathy cTnC G159D mutation whose Ca2+-sensitivity is not modulated by cTnI phosphorylation exhibits a structure inherently more rigid than WT, with phosphorylation reversing the direction of all metrics relative to WT.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: